Cargando…

497. Identification of Patients at Risk of Clostridium difficile Infection for Enrollment in Vaccine Clinical Trials

BACKGROUND: Vaccine efficacy trials against C. difficile infection (CDI) require a study population with an observed event rate that supports feasibility and timely study completion. The goal of this study was to develop a predictive algorithm to identify patients at high risk of developing CDI over...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stevens, Vanessa, Russo, Ellyn, Young-Xu, Yinong, Leecaster, Molly, Zhang, Yue, Zhang, Chong, Yu, Holly, Cai, Bing, Gonzalez, Elisa, Gerding, Dale N, Lawrence, Jody, Samore, Matthew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253404/ http://dx.doi.org/10.1093/ofid/ofy210.506

Ejemplares similares

An Economic Analysis of Strategies to Control Clostridium Difficile Transmission and Infection Using an Agent-Based Simulation Model
por: Nelson, Richard E., et al.
Publicado: (2016)

A Simulation-Based Assessment of Strategies to Control Clostridium Difficile Transmission and Infection
por: Rubin, Michael A., et al.
Publicado: (2013)

485. On- and Post-Antibiotic Effects on the Risk of Hospital-Acquired Clostridium difficile Infection (CDI)
por: Stevens, Vanessa, et al.
Publicado: (2018)

The Challenging Conundrum of Diagnosing and Managing Clostridium difficile Infection
por: Gerding, Dale N., et al.
Publicado: (2017)

Clostridium: Transmission difficile?
por: Harbarth, Stephan, et al.
Publicado: (2012)

The burden of clostridium difficile infection: estimates of the incidence of CDI from U.S. Administrative databases
por: Olsen, Margaret A., et al.
Publicado: (2016)

Identification of Medicare Recipients at Highest Risk for Clostridium difficile Infection in the US by Population Attributable Risk Analysis
por: Dubberke, Erik R., et al.
Publicado: (2016)

Cost analysis of an active surveillance strategy for Clostridium difficile using an agent-based simulation
por: Rubin, M, et al.
Publicado: (2015)

Clostridium difficile binary toxin CDT: Mechanism, epidemiology, and potential clinical importance
por: Gerding, Dale N, et al.
Publicado: (2014)

Non-toxigenic Clostridioides (Formerly Clostridium) difficile for Prevention of C. difficile Infection: From Bench to Bedside Back to Bench and Back to Bedside
por: Gerding, Dale N., et al.
Publicado: (2018)

Spore Formation and Toxin Production in Clostridium difficile Biofilms
por: Semenyuk, Ekaterina G., et al.
Publicado: (2014)

489. Validation of the SHEA/IDSA Severity Criteria to Predict Poor Outcomes Among Inpatients and Outpatients With Clostridium difficile Infection
por: Stevens, Vanessa, et al.
Publicado: (2018)

Toxin B is essential for virulence of Clostridium difficile
por: Lyras, Dena, et al.
Publicado: (2009)

1630 Excess Length of Stay Attributable to Clostridium difficile Infection (CDI) in the Acute Care Setting: A Multi-State Model
por: Stevens, Vanessa, et al.
Publicado: (2014)

Toxinotype V Clostridium difficile in Humans and Food Animals
por: Jhung, Michael A., et al.
Publicado: (2008)

Novel Fidaxomicin Treatment Regimens for Patients With Multiple Clostridium difficile Infection Recurrences That Are Refractory to Standard Therapies
por: Soriano, Melinda M., et al.
Publicado: (2014)

Use of Electronic Data to Identify Risk Factors Associated with Clostridium difficile Infection (CDI) and to Develop CDI Risk Scores
por: Aukes, Laurie, et al.
Publicado: (2017)

529 Frequent Transmission of Clostridium Difficile by Asymptomatically Colonized Long-term Care Facility Residents during Hospital Admissions
por: Donskey, Curtis J., et al.
Publicado: (2014)

Risk Factors for Primary Clostridium difficile Infection; Results From the Observational Study of Risk Factors for Clostridium difficile Infection in Hospitalized Patients With Infective Diarrhea (ORCHID)
por: Davies, Kerrie, et al.
Publicado: (2020)

Multihospital Outbreak of Clostridium difficile Infection, Cleveland, Ohio, USA
por: Jump, Robin L.P., et al.
Publicado: (2010)

Relapse Versus Reinfection: Recurrent Clostridium difficile Infection Following Treatment With Fidaxomicin or Vancomycin
por: Figueroa, Iris, et al.
Publicado: (2012)

Evaluation of the Xpert Clostridium difficile Assay for the Diagnosis of Clostridium difficile Infection
por: Shin, Saeam, et al.
Publicado: (2012)

The determinants of C. difficile infection in long-term care facilities: a portrait of patient- and facility-level factors across 90 care regions in the veterans affairs health care system
por: Brown, KA, et al.
Publicado: (2015)

518. Modeling the Potential Impact of Administering Vaccines Against Clostridium difficile Infection to Individuals in Healthcare Facilities
por: Toth, Damon, et al.
Publicado: (2018)

Efficacy of Bezlotoxumab in Participants Receiving Metronidazole, Vancomycin, or Fidaxomicin for Treatment of Clostridioides (Clostridium) difficile Infection
por: Dubberke, Erik R, et al.
Publicado: (2020)

Clostridium difficile Causing Empyema
por: Mohamed, Abdalla, et al.
Publicado: (2018)

1638 Clostridium difficile Strains Colonizing Long-Term Care Facility (LTCF) Residents are Similar to Strains Causing Infection in both LTCF and Hospital Patients Suggesting a Shared Continuum of Transmission
por: Pacheco, Susan M., et al.
Publicado: (2014)

Renal Failure and Leukocytosis Are Predictors of a Complicated Course of Clostridium difficile Infection if Measured on Day of Diagnosis
por: Bauer, Martijn P., et al.
Publicado: (2012)

Incidence and Costs of Clostridium difficile Infections in Canada
por: Levy, Adrian R., et al.
Publicado: (2015)

Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection in Patients at Increased Risk for Recurrence
por: Gerding, Dale N, et al.
Publicado: (2018)

Epidemiologic Trends in Clostridium difficile Isolate Ribotypes in United States from 2010 to 2014
por: Snydman, David R, et al.
Publicado: (2017)

Clearance of Vancomycin-Resistant Enterococcus Concomitant With Administration of a Microbiota-Based Drug Targeted at Recurrent Clostridium difficile Infection
por: Dubberke, Erik R., et al.
Publicado: (2016)

12. Randomized Studies of Two Clostridioides (Clostridium) difficile Vaccine Formulations
por: Lawrence, Jody, et al.
Publicado: (2020)

976. Clostridium difficile Colonization Molecular Epidemiology and Anti-toxin Serological Responses in Healthy Infants: A Prospective Cohort Study
por: Kociolek, Larry, et al.
Publicado: (2018)

Surface-Layer Protein A (SlpA) Is a Major Contributor to Host-Cell Adherence of Clostridium difficile
por: Merrigan, Michelle M., et al.
Publicado: (2013)

Etymologia: Clostridium difficile
Publicado: (2010)

Clostridium difficile Infection
por: Feuerstadt, Paul
Publicado: (2015)

Clostridium difficile infection
por: Geller, Stephen A., et al.
Publicado: (2014)

Clostridium difficile Infection
por: Magdesian, K. Gary
Publicado: (2003)

Gold Nanoclusters as an Antibacterial Alternative Against Clostridium difficile
por: Yang, Huan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cp9e53biraoihl9o0c8acv8isk